EPLP - Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income	$ 179,137	$ 444,304
Adjustments to reconcile net income to net cash provided by operating activities:
Straight-lined rents	393	332
Depreciation and amortization	308,968	302,788
Amortization of discount and debt financing costs, net	5,181	2,280
Realized and unrealized gains on marketable securities, net	(3,990)	(2,401)
Provision for credit losses	(222)	11
Company’s share of gain on the sales of co-investments	(9,231)	0
Equity income from co-investments	(28,099)	(22,186)
Operating distributions from co-investments	30,309	29,358
Accrued interest from notes and other receivables	(1,690)	(5,238)
Gain on the sale of real estate and land	(2,000)	(237,204)
Equity-based compensation	5,538	4,202
Loss on early retirement of debt	0	762
Gain on remeasurement of co-investment	0	(330)
Changes in operating assets and liabilities:
Prepaid expenses, receivables, operating lease right-of-use assets and other assets	8,222	2,008
Accounts payable, accrued liabilities and operating lease liabilities	49,353	(19,357)
Other liabilities	(637)	(1,697)
Net cash provided by operating activities	541,232	497,632
Additions to real estate:
Acquisitions of real estate and acquisition related capital expenditures, net of cash acquired	(3,902)	(585,132)
Redevelopment	(23,192)	(30,309)
Development acquisitions of and additions to real estate under development	(39,751)	(16,419)
Capital expenditures on rental properties	(51,326)	(64,450)
Investments in notes receivable	(59,500)	(281)
Collections of notes and other receivables	91,610	3,096
Proceeds from insurance for property losses	2,025	1,857
Proceeds from dispositions of real estate	2,000	364,155
Contributions to co-investments	(1,429)	(8,727)
Changes in refundable deposits	0	8,000
Purchases of marketable securities	(14,284)	(10,068)
Sales and maturities of marketable securities	23,860	188
Non-operating distributions from co-investments	31,250	18,000
Net cash used in investing activities	(42,639)	(320,090)
Cash flows from financing activities:
Proceeds from unsecured debt and mortgage notes	0	548,416
Payments on unsecured debt and mortgage notes	(450,545)	(615,502)
Proceeds from lines of credit and commercial paper	3,588,163	2,445,777
Repayments of lines of credit and commercial paper	(3,243,163)	(2,218,722)
Retirement of common stock	(61,915)	0
Additions to deferred charges	(576)	(5,393)
Payments related to debt prepayment penalties	0	(697)
Net costs from issuance of common units	(59)	(101)
Net proceeds from stock options exercised	898	8,930
Payments related to tax withholding for share-based compensation	(805)	(519)
Distributions to noncontrolling interest	(16,054)	(16,213)
Redemption of noncontrolling interests	(1,562)	(8,556)
Common units distributions paid	(332,217)	(322,924)
Net cash used in financing activities	(517,835)	(185,504)
Net decrease in unrestricted and restricted cash and cash equivalents	(19,242)	(7,962)
Unrestricted and restricted cash and cash equivalents at beginning of period	85,586	75,846
Unrestricted and restricted cash and cash equivalents at end of period	66,344	67,884
Supplemental disclosure of cash flow information:
Cash paid for interest (net of $2.8 million and $1.4 million capitalized in 2026 and 2025, respectively)	125,238	122,558
Operating cash flows from operating leases	3,029	3,291
Supplemental disclosure of noncash investing and financing activities:
Issuance of Operating Partnership units for contributed properties	250	0
Redemption of preferred equity investments upon acquisition of consolidated co-investments	0	94,669
Reclassifications to redeemable noncontrolling interest from general and limited partner capital and noncontrolling interest	3,483	2,073
Leased assets obtained in exchange for new operating lease liabilities	0	2,727
Essex Portfolio, L.P.
Cash flows from operating activities:
Net income	179,137	444,304
Adjustments to reconcile net income to net cash provided by operating activities:
Straight-lined rents	393	332
Depreciation and amortization	308,968	302,788
Amortization of discount and debt financing costs, net	5,181	2,280
Realized and unrealized gains on marketable securities, net	(3,990)	(2,401)
Provision for credit losses	(222)	11
Company’s share of gain on the sales of co-investments	(9,231)	0
Equity income from co-investments	(28,099)	(22,186)
Operating distributions from co-investments	30,309	29,358
Accrued interest from notes and other receivables	(1,690)	(5,238)
Gain on the sale of real estate and land	(2,000)	(237,204)
Equity-based compensation	5,538	4,202
Loss on early retirement of debt	0	762
Gain on remeasurement of co-investment	0	(330)
Changes in operating assets and liabilities:
Prepaid expenses, receivables, operating lease right-of-use assets and other assets	8,222	2,008
Accounts payable, accrued liabilities and operating lease liabilities	49,353	(19,357)
Other liabilities	(637)	(1,697)
Net cash provided by operating activities	541,232	497,632
Additions to real estate:
Acquisitions of real estate and acquisition related capital expenditures, net of cash acquired	(3,902)	(585,132)
Redevelopment	(23,192)	(30,309)
Development acquisitions of and additions to real estate under development	(39,751)	(16,419)
Capital expenditures on rental properties	(51,326)	(64,450)
Investments in notes receivable	(59,500)	(281)
Collections of notes and other receivables	91,610	3,096
Proceeds from insurance for property losses	2,025	1,857
Proceeds from dispositions of real estate	2,000	364,155
Contributions to co-investments	(1,429)	(8,727)
Changes in refundable deposits	0	8,000
Purchases of marketable securities	(14,284)	(10,068)
Sales and maturities of marketable securities	23,860	188
Non-operating distributions from co-investments	31,250	18,000
Net cash used in investing activities	(42,639)	(320,090)
Cash flows from financing activities:
Proceeds from unsecured debt and mortgage notes	0	548,416
Payments on unsecured debt and mortgage notes	(450,545)	(615,502)
Proceeds from lines of credit and commercial paper	3,588,163	2,445,777
Repayments of lines of credit and commercial paper	(3,243,163)	(2,218,722)
Retirement of common stock	(61,915)	0
Additions to deferred charges	(576)	(5,393)
Payments related to debt prepayment penalties	0	(697)
Net costs from issuance of common units	(59)	(101)
Net proceeds from stock options exercised	898	8,930
Payments related to tax withholding for share-based compensation	(805)	(519)
Distributions to noncontrolling interest	(4,613)	(4,718)
Redemption of noncontrolling interests	(1,562)	(8,556)
Common units distributions paid	(343,658)	(334,419)
Net cash used in financing activities	(517,835)	(185,504)
Net decrease in unrestricted and restricted cash and cash equivalents	(19,242)	(7,962)
Unrestricted and restricted cash and cash equivalents at beginning of period	85,586	75,846
Unrestricted and restricted cash and cash equivalents at end of period	66,344	67,884
Supplemental disclosure of cash flow information:
Cash paid for interest (net of $2.8 million and $1.4 million capitalized in 2026 and 2025, respectively)	125,238	122,558
Operating cash flows from operating leases	3,029	3,291
Supplemental disclosure of noncash investing and financing activities:
Issuance of Operating Partnership units for contributed properties	250	0
Redemption of preferred equity investments upon acquisition of consolidated co-investments	0	94,669
Reclassifications to redeemable noncontrolling interest from general and limited partner capital and noncontrolling interest	3,483	2,073
Leased assets obtained in exchange for new operating lease liabilities	$ 0	$ 2,727